NOX 4.17% 6.9¢ noxopharm limited

Ann: New Independent Trial Data Supports Potential of Veyonda, page-3

  1. 1,456 Posts.
    lightbulb Created with Sketch. 492
    How do the WARMTH and Vision trials differ?
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.